Wednesday, June 10, 2026

Patent directory · USPTO A61K / A61P

Patents matching “administration”

271 pharma patents match "administration" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 271
Index total 30,257
Page 5 / 12

Quick answer

This filtered view shows 271 pharmaceutical patents matching "administration" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

271 results for “administration” · 30,257 patents in full index Clear search

  1. CA 3159588

    VIRUS MVA RECOMBINANTS POUR L'ADMINISTRATION INTRATUMORALE ET/OU INTRAVEINEUSE POUR LE TRAITEMENT DU CANCER

    BAVARIAN NORDIC AS [DK] · Granted May 27, 2021 · Expires May 22, 2041

    granted
  2. US 11013707

    Administration of oral methyldopa

    The Regents of the University of Colorado, a Body Corporate · Granted May 25, 2021 · Expires May 20, 2041

    granted
  3. US 10993941

    Methods for the administration of certain VMAT2 inhibitors

    Neurocrine Biosciences, Inc. · Granted May 4, 2021 · Expires Apr 29, 2041

    granted
  4. US 10952997

    Methods for the administration of certain VMAT2 inhibitors

    Neurocrine Biosciences, Inc. · Granted Mar 23, 2021 · Expires Mar 18, 2041

    granted
  5. US 10940141

    Methods for the administration of certain VMAT2 inhibitors

    Neurocrine Biosciences, Inc. · Granted Mar 9, 2021 · Expires Mar 4, 2041

    granted
  6. US 10912771

    Methods for the administration of certain VMAT2 inhibitors

    Neurocrine Biosciences, Inc. · Granted Feb 9, 2021 · Expires Feb 4, 2041

    granted
  7. US 10881714

    Methods and compositions for oral administration of proteins

    Oramed Ltd. · Granted Jan 5, 2021 · Expires Dec 31, 2040

    granted
  8. US 10874648

    Methods for the administration of certain VMAT2 inhibitors

    Neurocrine Biosciences, Inc. · Granted Dec 29, 2020 · Expires Dec 24, 2040

    granted
  9. US 10864181

    Method of administration of gamma hydroxybutyrate with monocarboxylate transporters

    Jazz Pharmaceuticals Ireland Limited · Granted Dec 15, 2020 · Expires Dec 10, 2040

    granted
  10. US 10857148

    Methods for the administration of certain VMAT2 inhibitors

    Neurocrine Biosciences, Inc. · Granted Dec 8, 2020 · Expires Dec 3, 2040

    granted
  11. US 10857137

    Methods for the administration of certain VMAT2 inhibitors

    Neurocrine Biosciences, Inc. · Granted Dec 8, 2020 · Expires Dec 3, 2040

    granted
  12. US 10842800

    Concomitant administration of glucocorticoid receptor modulators and CYP3A inhibitors

    Corcept Therapeutics Incorporated · Granted Nov 24, 2020 · Expires Nov 19, 2040

    granted
  13. US 10772861

    Administration of serine protease inhibitors to the stomach

    The Regents of the University of California · Granted Sep 15, 2020 · Expires Sep 10, 2040

    granted
  14. US 10772913

    Administration of kynurenine depleting enzymes for tumor therapy

    The Board of Regents of the University of Texas System · Granted Sep 15, 2020 · Expires Sep 10, 2040

    granted
  15. US 10736975

    Infusion administration of conjugated monoclonal antibodies

    Actinium Phamaceuticals, Inc. · Granted Aug 11, 2020 · Expires Aug 6, 2040

    granted
  16. US 10729643

    Methods for administration and methods for treating cardiovascular diseases with resiniferatoxin

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Aug 4, 2020 · Expires Jul 30, 2040

    granted
  17. US 10716793

    Treprostinil administration by inhalation

    United Therapeutics Corporation · Granted Jul 21, 2020 · Expires Jul 16, 2040

    granted
  18. US 2020155578

    Pharmaceutical Formulations for Subcutaneous Administration

    ABBVIE INC [US] · Granted May 21, 2020 · Expires May 16, 2040

    granted
  19. US 10646481

    Pharmaceutical composition and administrations thereof

    Vertex Pharmaceuticals Incorporated · Granted May 12, 2020 · Expires May 7, 2040

    granted
  20. US 10646438

    Methods for inducing an immune response via buccal and/or sublingual administration of a vaccine

    The Board of Regents of the University of Texas System · Granted May 12, 2020 · Expires May 7, 2040

    granted
  21. CA 3116885

    COMPOSITIONS ET METHODES D'ADMINISTRATION DE TRANSGENE

    CRISPR THERAPEUTICS AG [CH] · Granted Apr 23, 2020 · Expires Apr 18, 2040

    granted
  22. US 10543283

    Intranasal administration of guanidinylated aminoglycosides

    The Regents of the University of California · Granted Jan 28, 2020 · Expires Jan 23, 2040

    granted
  23. US 10464992

    VEGF antagonist formulations suitable for intravitreal administration

    REGENERON PHARMACEUTICALS, INC. · Granted Nov 5, 2019 · Expires Oct 31, 2039

    granted
  24. US 10400025

    VEGF antagonist formulations suitable for intravitreal administration

    REGENERON PHARMACEUTICALS, INC. · Granted Sep 3, 2019 · Expires Aug 29, 2039

    granted